Regional differences in gene expression for calcium activated neutral proteases (calpains) and their endogenous inhibitor calpastatin in mouse brain and spinal cord

Journal of Neurobiology

Volumn 30, Issue 2, 1996, Pages 177-191

  Li, Jinhe ^a   Grynspan, Frida ^a   Berman, Stephen ^a   Nixon, Ralph ^a   Bursztajn, Sherry ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

calpains; calpastatin; in situ hybridization; motor neurons; mRNA distribution

Indexed keywords

CALPAIN; CALPASTATIN;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVATION; ENZYME LOCALIZATION; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; MOTONEURON; MOUSE; NEOCORTEX; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; TISSUE DISTRIBUTION;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; BRAIN; CALCIUM-BINDING PROTEINS; CALPAIN; CYSTEINE PROTEINASE INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD; TRANSCRIPTION, GENETIC;

EID: 0029935974     PISSN: 00223034     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4695(199606)30:2<177::AID-NEU1>3.0.CO;2-2     Document Type: Article

References (87)

1. ADACHI, Y., KITAHARA-OZAWA, A., SUGAMURA, K., LEE, W. J., YODOI, J., MAKI, M., MURACHI, T., HATANAKA, M. (1992). Expression of calpain II gene in human hematopoietic system cells infected with human T-cell leukemia virus type I. J. Biol. Chem. 267: 19373-19378.
2. ALEXIANU, M. E., Ho, B. K., MOHAMED, A. H., LA-BELLA, V., SMITH, R. G., and APPEL, S. H. (1994). The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann. Neurol. 36:846-858.
3. APPEL, S. H., SMITH, R. G., ALEXIANU, M., ENGELHARDT, J., MOSIER, D., COLOM, L., and STEFANI, E. (1994). Neurodegenerative disease: Autoimmunity involving calcium channels. Ann. NY Acad. Sci. 747: 183-194.
4. ARAI, A., KESSLER, M., LEE, K., and LYNCH, G. (1990). Calpain inhibitors improve the recovery of synaptic transmission from hypoxia in hippocampal slices. Brain Res. 532:63-68.
5. ASADA, K., ISHINO, Y., SHIMADA, M., SHIMOJO, T., ENDO, M., KIMIZUKA, F., KATO, I., MAKI, M., HATANAKA, M., and MURACHI, T. (1989). cDNA cloning of human calpastatin: sequence homology among human, pig, and rabbit calpastatins. J. Enzyme Inhibition 3:49-56.
6. BANAY-SCHWARTZ, M., DEGUZMAN, T., PALKOVITS, M., and LAJTHA, A. (1994). Calpain activity in adult and aged human brain regions. Neurochem. Res. 19: 563-567.
7. BARTUS, R. T., HAYWARD, N. J., ELLIOTT, P. J., SAWYER, S. D., BAKER, K.. L, DEAN, R. L., AKIYAMA, A., STRAUB, J. A., HARBESON, S. L., Li, Z., et al. (1994). Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration. Stroke 25:2265-2270.
8. BAUDRY, M. and LYNCH, G. (1980). Regulation of hippocampal glutamate receptors: Evidence for the involvement of a calcium-activated protease. Proc. Natl. Acad. Sci. USA 77:2298-2302.
9. BURSZTAJN, S., BERMAN, S, A., and GILBERT, W. (1989). Differential expression of acetylcholine receptor mRNA in nuclei of cultured muscle cells. Proc. Natl. Acad. Sci. USA 86:2928-2932.
10. CANER, H., COLLINS, J. L., HARRIS, S. M., KASSELL, N. F., and LEE, K. S. (1993). Attenuation of AMPA-induced neurotoxicity by a calpain inhibitor. Brain Res. 607:354-356.
11. CHENG, Y. and SUN, A. Y. (1994). Oxidative mechanisms involved in kainate-induced cytotoxicity in cortical neurons. Neurochem. Res. 19:1557-1564.
12. CHENG, Y., WIXOM, P., JAMES-KRACKE, M. R., and SUN, A. Y. (1994). Effects of extracellular ATP on Fe(2+)-induced cytotoxicity in PC-12 cells. J. Neurochem. 63:895-902.
13. CORFAS, G., ROSEN, K. M., ARATAKE, H., KRAUSS, R., and FISCHBACH, G. D. (1995). Differential expression of ARIA isoforms in the rat brain. Neuron 14:103-115.
14. CROALL, D. E. and DEMARTINO, G. N. (1991). Calcium-activated neutral protease (calpain) system: Structure, function, and regulation [Review]. Physiol. Rev. 71:813-847.
15. DELUCA, C. I., DAVIES, P. L., SAMIS, J. A., and ELCE, J. S. (1993). Molecular cloning and bacterial expression of cDNA for rat calpain II 80 kDa subunit. Biochim. Biophys. Acta 1216:81-93.
16. FISHER, T. J., VRBOVA, G., and WIJETUNGE, A. (1989). Partial denervation of the rat soleus muscle at two different developmental stages. Neurosci. 28:755-763.
17. FUKUDA, T., ADACHI, E., KAWASHIMA, S., YOSHIYA, I., and HASHIMOTO, P. H. (1990). Immunohistochemical distribution of calcium-activated neutral proteinases and endogenous CANP inhibitor in the rabbit hippocampus. J. Comp. Neurol 302:100-109.
18. GLASER, T. and KOSOWER, N. S. (1986). Calpain-calpastatin and fusion. Fusibility of erythrocytes is determined by a protease-protease inhibitor [calpain-calpastatin] balance. FEBS Lett. 206:115-120.
19. GOLL, D. E., THOMPSON, V. F., TAYLOR, R. G., and ZALEWSKA, T. (1992). Is calpain activity regulated by membranes and autolysis or by calcium and calpas-tatin? BioEssays 14:549-556.
20. GOTO, K., IWAMOTO, T., and KONDO, H. (1994). Localization of messenger RNAs for calpain and calpastatin in the adult rat brain by in situ hybridization histochemistry. Mol. Brain Res. 23:40-46.
21. GUROFF, G. A. (1964). A neutral calcium-activated protease from the soluble fraction of rat brain. J. Biol. Chem. 239:149-155.
22. GUSTAVSSON, S. and KARLSSON, J. O. (1986). In situ degradation of rapidly transported proteins in nerve terminals of retinal ganglion cells. Neurosci. Lett. 63: 221-224.
23. HAMAKUBO, T., KANNAGI, R., MURACHI, T., and MATUS, A. (1986). Distribution of calpains I and II in rat brain. J. Neurosci. 6:3103-3111.
24. HASEL, K. W., GLASS, J. R., GODBOUT, M., and SUTCLIFFE, J. G. (1991). An endoplasmic reticulum-specific cyclophilin. Mol. Cell. Biol. 11:3484-3491.
25. HATA, A., OHNO, S., AKITA, Y., and SUZUKI, K. (1989). Tandemly reiterated negative enhancer-like elements regulate transcription of a human gene for the large subunit of calcium-dependent protease. J. Biol. Chem. 264:6404-6411.
26. HATA, A., OHNO, S., and SUZUKI, K. (1992). Transcriptional activation of the gene for the large subunit of human m-calpain by 12-o-tetradecanoyl-phorbol-13-acetate. FEBS Lett. 304:241-244.
27. ISHIDA, S., EMORI, Y., and SUZUKI, K. (1991). Rat calpastatin has diverged primary sequence from other mammalian calpastatins but retains functionally important sequences. Biochem. Biophys. 1088:436-438.
28. IWAMOTO, N., THANGNIPON, W., CRAWFORD, C., and EMSON, P. C. (1991). Localization of calpain immunoreactivity in senile plaques and in neurones undergoing neurofibrillary degeneration in Alzheimer's disease. Brain Res. 561:177-180.
29. JOHNSON, R. (1990). Calpains (intracellular calcium-activated cysteine proteinases): Structure-activity relationships and involvement in normal and abnormal cellular metabolism. Int. J. Biochem. 22:811-822.
30. KAGEYAMA, R. and PASTAN, I. (1989). Molecular cloning and characterization of a human DNA binding factor that represses transcription. Cell 59:815-825.
31. KAMAKURA, K., ISHIURA, S., SUZUKI, K., SUGITA, H., and TOYOKURA, Y. (1985). Calcium-activated neutral protease in the peripheral nerve, which requires micro molar Ca2+, and its effect on the neurofilament triplet. J. Neurosci. Res. 13:391-403.
32. KATAYAMA, S., SAITO, K., CATALDO, A., HUNDA, T., GRYNSPAN, F., GRIFFIN, W., MOHAN, P. S., SCHWAGERL, A. L., and NIXON, R. A. (1994). Abnormalities of the calpain system in Alzheimer disease. Soc. Neurosis Abstr. 20:1035.
33. LADURON, P. M. (1987). Axonal transport of neuroreceptors: Possible involvement in long-term memory [Review]. Neuroscience 22:767-779.
34. LEE, W. J., HATANAKA, M., and MAKI, M. (1992a). Multiple forms of rat calpastatin cDNA in the coding region of functionally unknown amino-terminal domain. Biochim. Biophys. Acta 1129:251-253.
35. LEE, W. J., MA, H., TAKANO, E., YANG, H. Q., HATANAKA, M., and MAKI, M. (1992b). Molecular diversity in amino-terminal domains of human calpastatin by exon skipping. J. Biol. Chem. 267:8437-8442.
36. LERNER, R. A., GREEN, N., ALEXANDER, H., LIU, F. T., SUTCLIFFE, J. G., and SHINNICK, T. M. (1981). Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc. Natl. Acad. Sci. USA 78: 3403-3407.
37. LITERSKY, J. M., SCOTT, C. W., and JOHNSON, G. V. W. (1993). Phosphorylation, calpain protiolysis and turulin binding of recombinant human tau isoforms. Brain Res. 604:32-40.
38. LYNCH, G. and BAUDRY, M. (1984). The biochemistry of memory: A new and specific hypothesis. Science 224:1057-1063.
39. LYNCH, G. and BAUDRY, M. (1987). Brain spectrin, calpain and long-term changes in synaptic efficacy [Review]. Brain Res. Bull. 18:809-815.
40. LYNCH, G., LARSON, J., and BAUDRY, M. (1986). Proteases, neuronal stability, and brain aging: An hypothesio. In: Treatment Development Strategies for Alzheimer's Disease. T. Crook, R. Bartus, S. Ferris, S. Gershon, Eds. Mark Powley Assoc., Madison, CT, pp. 119-149.
41. MACLEOD, D. P. (1991-1992). Environmental trace metal abnormalities and amyotrophic lateral sclerosis - An aetiological role for calpain I? [Letter]. Magnesium Trace Elements 10:51-52.
42. MELLGREN, R. L. (1980). Canine cardiac calcium-dependent proteases: Resolution of two forms with different requirements for calcium. FEBS Lett. 109: 129-133.
43. MELLGREN, R. L. and ROZANOV, C. B. (1990). Calpain II!-dependent solubilization of a nuclear protein kinase at micromolar calcium concentrations. Biochem. & Biophys. Res. Comm. 168:589-595.
44. MERCKEN, M., GRYNSPAN, F., and NIXON, R. A. (1995). Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau. FEBS Lett.
45. MOHAN, P., LOYA, S., AVIDAN, O., VERMA, S., DHINDSA, G. S., WONG, M. F., HUANG, P. P., YASHIRO, M., BABA, M., and HIZI, A. (1994). Synthesis of naphthalenesulfonic acid small molecules as selective inhibitors of the DNA polymerase and ribonuclease H activities of HIV-1 reverse transcriptase. J. Medicinal Chem. 37:2513-2519.
46. MORRIS, R. G., HAGAN, J. J., NADEL, L., JENSEN, J., BAUDRY, M., and LYNCH,G. S. (1987). Spatial learning in the rat: Impairment induced by the thiol-proteinase inhibitor, leupeptin, and an analysis of [3H]glutamate receptor binding in relation to learning. Behav. Neural Biol. 47:333-345.
47. MORTENSEN, A. M. and NOVAK, R. F. (1991). Enhanced proteolysis and changes in membrane-associated calpain following phenylhydrazine insult to human red cells. Toxicol. Appl. Pharmacol. 110:435-449.
48. MURACHI, T. (1989). Intracellular regulatory system involving calpain and calpastatin. Biochem. Int. 18:263-294.
49. MURACHI, T., TANAKA, K., HATANAKA, M., and MURAKAMI, T. (1981). Intracellular Ca+-dependent protease (calpain) and its high-molecular-weight endogenous inhibitor (calpastatin). Adv. Enzyme Regul. 19: 407-424.
50. MURATA, M., MONDEN, M., UMESHITA, K., NAKANO, H., KANAI, T., GOTOH, M., and MORI, T. (1994). Role of intracellular calcium in superoxide-induced hepatocyte injury. Hepatology 19:1223-1228.
51. MURPHY, G. M. Jr., JIA, X. C., Yu, A. C., LEE, Y. L., TINKLENBERG, J. R., and ENG, L. F. (1993). Reverse transcription and polymerase chain reaction technique for quantification of m RNA in primary astrocyte cultures. J. Neurosci. Res. 35:643-651.
52. NAKAMURA, M., MORI, M., MORISHITA, Y., MORI, S., and KAWASHIMA, S. (1992). Exp. Cell Res. 200:513-522.
53. NAKAMURA, M., MORI, M., MORISHITA, Y., MORI, S., and KAWASHIMA, S. (1994). Specific increase in calcium-activated neutral protease with low calcium sensitivity (m-calpain) in proerythroblastic K562 cell line cells induced to differentiation by phorbol 12-myristate 13-acetate. Exp. Cell Res. 200:513-522.
54. NICOLL, R. A., KAUER, J. A., and MALENKA, R. C. (1988). The current excitement in long-term potentiation [Review]. Neuron 1:97-103.
55. NILSSON, E., ALAFUZOFF, I., BLENNOW, K., BLOMGREN, K., HALL, C. M., JANSON, I., KARLSSON, I., WALLIN, A., GOTTFRIES, C. G., and KARLSSON, J. O. ( 1990). Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue. Neurobiol. Aging 11:425-431.
56. NIXON, R. A. (1989). Calcium-activated neutral proteinases as regulators of cellular function. Implications for Alzheimer's disease pathogenesis [Review]. Ann. NY Acad. Sci. 568:198-208.
57. NIXON, R. A., SAITO, K.-I., GRYNSPAN, F., GRIFFIN, W., KATAYAMA, S., HONDA, T., MOHAN, P., SHEA, T., and BEERMANN, M. (1994). The calpain calpastatin system in aging and Alzheimer disease. Ann. NY Acad. Sci.
58. O'BRIEN, R. A., OSTBERG, A. J., and VRBOVA, G. (1984). Protease inhibitors reduce the loss of nerve terminals induced by activity and calcium in developing rat soleus muscles in vitro. Neuroscience 12:637-646.
59. PERLMUTTER, L. S., GALL, C., BAUDRY, M., and LYNCH, G. (1990). Distribution of calcium-activated protease calpain in the rat brain. J. Camp. Neurol. 296:269-276.
60. PERLMUTTER, L. S., SIMAN, S., GALL, C., SEUBERT, P., BAUDRY, M., and LYNCH, G. (1988). The ultrastructural localization of calcium-activated protease "calpain" in rat brain. Synapse 2:79-88.
61. PONTREMOLI, S., MELLONI, E., DAMIANI, G., SALAMINO, F., SPARATORE, B., MICHETTI, M., and HORECKER, B. L. (1988). Effects of a monoclonal anti-calpain antibody on responses of stimulated human neutrophils. Evidence for a role for proteolytically modified protein kinase. Can. J. Biol. Chem. 263: 1915-1919.
62. PONTREMOLI, S., MELLONI, E., MICHETTI, M., SPARATORE, B., SALAMINO, F., SACCO, O., and HORECKER, B. L. (1987a). Phosphorylationandproteolyticmodification of specific cytoskeletal proteins in human neutrophils stimulated by phorbol 12-myristate 13-acetate. Proc Natl. Acad. Sci. USA 84:3604-3608.
63. PONTREMOLI, S., MELLONI, E., MICHETTI, M., SPARATORE, B., SALAMINO, F., SACCO, O., and HORECKER, B.L. (1987b). Phosphorylation by protein kinase C of a 20-kDa cytoskeletal polypeptide enhances its susceptibility to digestion by calpain. Proc. Natl. Acad. Sci. USA 84:398-401.
64. PONTREMOLI, S., VIOTTI, P. L., MICHETTI, M., SPARATORE, B., SALAMINO, F., and MELLONI, E. (1990). Identification of an endogenous activator of calpain in rat skeletal muscle. Biochem. & Biophys. Res. Comm. 171:569-574.
65. RAMI, A. and KRIEGLSTEIN, J. (1993). Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res. 609:67-70.
66. ROBERTS-LEWIS, J. M., MARCY, V. R., ZHAO, Y., VAUGHT, J. L., SIMAN, R., and LEWIS, M. E. (1993). Aurintricarboxylic acid protects hippocampal neurons from NMDA- and ischemia-induced toxicity in vivo. J. Neurochem. 61:378-381.
67. ROOTS, B. I. (1983). Neurofilament accumulation induced in synapses by leupeptin. Science 221:971-972.
68. ROSEN, D. R., SIDDIQUE, T., PATTERSON, D., FIGLEWICZ, D. A., SAPP, P., HENTATI, A., DONALDSON, D., GOTO, J., O'REGAN, J. P., DENG, H. X., et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62 [Erratum 364:362, see comments].
69. ROTHSTEIN, J. D., BRISTOL, L. A., HOSLER, B., BROWN, R. H. Jr., and KUNCL, R. W. (1994). Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc. Natl. Acad. Sci. USA 91: 4155-4159.
70. SAIDO, T. C., SUZUKI, H., YAMAZAKI, H., TANOUE, K., and SUZAKI, K. (1986). Possible role of calpain land calpain II in differentiating muscle. Exp. Cell Res. 163: 413-422.
71. SAIDO, T. D., YOKOTA, M., NAGAO, S., YAMAURA, I., TANI, E., TSUCHIYA, T., SUZUKI, K., and KAWASHIMA, S. (1993). Spatial resolution of fodrin proteolysis in postischemic brain. J. Biol. Chem. 268:25239-25243.
72. SAMBROOK, J., FRITSCH, E. F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
73. SCHOLLMEYER, J. E. (1986). Role of Ca2+ and Ca2+-activated protease in myoblast fusion. Exp. Cell Res. 162:411-422.
74. SIEBERT, P. D. and LARRICK, J. W. (1992). Competitive PCR. Nature 359:557-558.
75. SIMAN, R. (1992). Proteolytic mechanism for the neurodegeneration of Alzheimer'sdisease. Ann. NY Acad. Sci. 674:193-202.
76. SIMAN, R., AHDOOT, M., and LYNCH, G. (1987). Ontogeny, compartmentation, and turnover of spectrin isoforms in rat central neurons. J. Neurosci. 7:55-64.
77. SIMAN, R., BAUDRY, M., and LYNCH, G. (1985a). Regulation of glutamate receptor binding by the cytoskeletal protein fodrin. Nature 313:225-228.
78. SIMAN, R., GALL, C., PERLMUTTER, L. S., CHRISTIAN, C., BAUDRY, M., and LYNCH, G. (1985b). Distribution of calpain I. an enzyme associated with degenerative activity, in rat brain. Brain Res. 347:399-403.
79. SIMAN, R. and NOSZEK, J. C. (1988). Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1:279-287.
80. SIMAN, R., NOSZEK, J. C., and KEGERISE, C. (1989). Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J. Neurosci. 9:1579-1590.
81. SONG, D. K., MALMSTRAN, T., KATER, S. B., and MYKLES, D. L. (1994). Calpain inhibitors block Ca2+-induced suppression of neunte outgrowth in isolated hippocampal pyramidal neurons. J. Nenrosci. Res. 39:474-481.
82. SUZUKI, K. and OHNO, S. (1990). Calcium activated neutral protease - structure-function, relationship and functional implications. [Review]. Cell Structure & Function 15:1-6.
83. SWANSON, G. and VRBOVA, G. (1987). Effects of low calcium and inhibition of calcium activated neutral protease on mature nerve terminal structure in the rat sternocostalis muscle. Div. Brain Res. 33:199-203.
84. WATKINS, S. (1989). In situ hybridization and immunohistochemistry: Cryosectioning. In: Current Protocols in Molecular Biology, Supplement 7. F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, eds. pp. 14.2.1-14.2.8.
85. WEIH, F., STEWART, A. F., and SCHUTZ, G. (1988). A novel and rapid method to generate single stranded DNA probes for genomic footprinting. Nucl. Acid Res. 16:1628.
86. ZIMMERMAN, U. J. and SCHLAEPFER, W. W. (1984). Calcium-activated neutral protease (CANP) in brain and other tissues [Review]. Prog. Neurobiol. 23:63-78.
87. ZIMMERMAN, U. P. and SCHLAEPFER, W. W. (1984). Multiple forms of Ca-activated protease from rat brain and muscle. J. Biol. Chem 259:3210-3218.